← Open Payments lookup

JAMES RIDDLE: Open Payments

NPI 1225003973 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$484 in 24 payments from 8 companies in 2025. Trend: 2023 $866 · 2024 $1,181 · 2025 $484

Food & beverage: $484
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$120
Otsuka America Pharmaceutical, Inc.5$81
Alkermes, Inc.4$81
E.R. Squibb & Sons, L.L.C.4$76
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$52
Teva Pharmaceuticals USA, Inc.2$31
ABBVIE INC.1$25
Vanda Pharmaceuticals Inc.1$19

Products named: INGREZZA, COBENFY, ARISTADA, CAPLYTA, ABILIFY MAINTENA, LYBALVI, ABILIFY ASIMTUFII, HETLIOZ.

Industry payments across SC — which companies pay providers there.